An investigation on the effect of memantine on children with autistic spectrum disorder

Not Applicable

• Conditions: patients diagnosed with ASD.; Autistic disorder; F84.0

• Registration Number: IRCT20211118053097N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Patients diagnosed with ASD according to DSM 5
Patients with no previous history of epilepsy and/or abnormal electroencephalography
Patients aged between 4 to 12 years old

Exclusion Criteria

Intolerance to Memantine
Patients and/or their caregiver’s disinclination to continuing with trail

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Electroencephalography analysis. Timepoint: Before the treatment and 10 weeks after treatment onset. Method of measurement: Using the Electroencephalograph and analysis of activities.;ABC questionnaire (measuring cognitive activity). Timepoint: Before the treatment and 10 weeks after treatment onset. Method of measurement: Filling ABC autism questionnaire.